A new investigational therapy could be a major breakthrough in the treatment of both diabetes and fatty liver, according to Weill Cornell Medicine investigators.
Diabetes is a disease in which the pancreas either does not produce enough insulin or cells in the body fail to respond to insulin properly. Diabetic patients experience abnormally high blood sugar levels, which can lead to heart disease, stroke, kidney failure, and eye damage. The disease, which...